{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:14:21Z","timestamp":1777032861979,"version":"3.51.4"},"reference-count":39,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.2169\/internalmedicine.6267-20","type":"journal-article","created":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T22:09:35Z","timestamp":1607292575000},"page":"1331-1342","source":"Crossref","is-referenced-by-count":10,"title":["Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification"],"prefix":"10.2169","volume":"60","author":[{"given":"Tsuyoshi","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Takami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Sakaida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0016-5085(84)80106-7","volume":"86","author":"K Okuda","year":"1984","unstructured":"1. Okuda K, Kono K, Ohnishi K, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86: 600-610, 1984.","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"2","first-page":"573","volume":"41","author":"RJ Gusberg","year":"1994","unstructured":"2. Gusberg RJ, Peterec SM, Sumpio BE, Meier GH. Splenomegaly and variceal bleeding-hemodynamic basis and treatment implications. Hepatogastroenterology 41: 573-577, 1994.","journal-title":"Hepatogastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0172-6390","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Spigos DG, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol 132: 777-782, 1979.","DOI":"10.2214\/ajr.132.5.777"},{"key":"4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep.1840180214","volume":"18","author":"B Sangro","year":"1993","unstructured":"4. Sangro B, Bilbao I, Herrero I, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18: 309-314, 1993.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology 22: 1682-1688, 1995.","DOI":"10.1016\/0270-9139(95)90191-4"},{"key":"6","unstructured":"6. N'Kontchou G, Seror O, Bourcier V, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 17: 179-184, 2005."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mukaiya M, Hirata K, Yamashiro K, Katsuramaki T, Kimura H, Denno R. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO). Cancer Chemother Pharmacol 33 (Suppl): S37-S41, 1994.","DOI":"10.1007\/BF00686666"},{"key":"8","first-page":"1847","volume":"54","author":"F Chikamori","year":"2007","unstructured":"8. Chikamori F, Kuniyoshi N, Kawashima T, Takase Y. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism. Hepatogastroenterology 54: 1847-1849, 2007.","journal-title":"Hepatogastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0172-6390","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/apm.12470","volume":"123","author":"AZ Helaly","year":"2015","unstructured":"9. Helaly AZ, Al-Warraky MS, El-Azab GI, Kohla MA, Abdelaal EE. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism. APMIS 123: 1032-1039, 2015.","journal-title":"Apmis","ISSN":"https:\/\/id.crossref.org\/issn\/0903-4641","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhao Y, Guo L, Huang Q, et al. Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradient. Medicine (Baltimore) 98: e17900, 2019.","DOI":"10.1097\/MD.0000000000017900"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ohmoto K, Yoshioka N, Tomiyama Y, et al. Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci 51: 352-358, 2006.","DOI":"10.1007\/s10620-006-3137-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Duan X, Zhang K, Han X, et al. Comparison of percutaneous transhepatic variceal embolization (PTVE) followed by partial splenic embolization versus PTVE alone for the treatment of acute esophagogastric variceal massive hemorrhage. J Vasc Interv Radiol 25: 1858-1865, 2014.","DOI":"10.1016\/j.jvir.2014.08.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Buechter M, Kahraman A, Manka P, et al. Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation. PLoS One 12: e0177401, 2017.","DOI":"10.1371\/journal.pone.0177401"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ishikawa T, Sasaki R, Nishimura T, et al. A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification. PLoS One 14: e0223153, 2019.","DOI":"10.1371\/journal.pone.0223153"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vujic I, Lauver JW. Severe complications from partial splenic embolization in patients with liver failure. Br J Radiol 54: 492-495, 1981.","DOI":"10.1259\/0007-1285-54-642-492"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hayashi H, Beppu T, Masuda T, et al. Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients. J Hepatobiliary Pancreat Sci 21: 51-57, 2014.","DOI":"10.1002\/jhbp.1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lee CM, Leung TK, Wang HJ, et al. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol 13: 619-622, 2007.","DOI":"10.3748\/wjg.v13.i4.619"},{"key":"18","first-page":"518","volume":"38","author":"CT Wai","year":"2003","unstructured":"18. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526, 2003.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46: 32-36, 2007.","DOI":"10.1002\/hep.21669"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shimizu H, Takatsuka K, Yoshida A, Yoshimatsu E, Matsui K, Iwabuchi S. Partial splenic embolization reverses insulin resistance in patients with liver cirrhosis. Intern Med 48: 747-751, 2009.","DOI":"10.2169\/internalmedicine.48.1649"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ishikawa T, Shiratsuki S, Matsuda T, et al. Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension. J Gastroenterol 49: 1333-1341, 2014.","DOI":"10.1007\/s00535-013-0893-z"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ishikawa T, Aibe Y, Matsuda T, Iwamoto T, Takami T, Sakaida I. Plasma glucose level is predictive of serum ammonia level after retrograde occlusion of portosystemic shunts. AJR Am J Roentgenol 209: W169-W176, 2017.","DOI":"10.2214\/AJR.16.17307"},{"key":"23","unstructured":"23. Akahane T, Iwasaki T, Kobayashi N, et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 92: 1026-1030, 1997."},{"key":"24","unstructured":"24. Murray CD. The physiological principle of minimum work: I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A 12: 207-214, 1926."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science 312: 104-107, 2006.","DOI":"10.1126\/science.1123842"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Matsuo R, Ohkohchi N, Murata S, et al. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res 145: 279-286, 2008.","DOI":"10.1016\/j.jss.2007.02.035"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg 253: 759-763, 2011.","DOI":"10.1097\/SLA.0b013e318211caf8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Akahoshi T, Hashizume M, Tanoue K, et al. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 17: 59-65, 2002.","DOI":"10.1046\/j.1440-1746.2002.02667.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kato M, Shimohashi N, Ouchi J, et al. Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism. J Gastroenterol 40: 1076-1077, 2005.","DOI":"10.1007\/s00535-005-1693-x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lautt WW, Legare DJ, d'Almeida MS. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol 248: H331-H338, 1985.","DOI":"10.1152\/ajpheart.1985.248.3.H331"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mathie RT, Alexander B. The role of adenosine in the hyperaemic response of the hepatic artery to portal vein occlusion (the 'buffer response'). Br J Pharmacol 100: 626-630, 1990.","DOI":"10.1111\/j.1476-5381.1990.tb15857.x"},{"key":"32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/jhep.2002.31722","volume":"35","author":"V G\u00fclberg","year":"2002","unstructured":"32. G\u00fclberg V, Haag K, R\u00f6ssle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 35: 630-634, 2002.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Kleber G, Steudel N, Behrmann C, et al. Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion. Gastroenterology 116: 906-914, 1999.","DOI":"10.1016\/S0016-5085(99)70074-0"},{"key":"34","unstructured":"34. Rocheleau B, Ethier C, Houle R, Huet PM, Bilodeau M. Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis. Am J Physiol 277: G1000-G1007, 1999."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Wakui N, Nagai H, Ogino Y, et al. Hepatic arterialization can predict the development of collateral veins in patients with HCV-related liver disease. J Ultrasound 21: 301-308, 2018.","DOI":"10.1007\/s40477-018-0323-4"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sakai T, Shiraki K, Inoue H, et al. Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci 47: 388-391, 2002.","DOI":"10.1023\/A:1013786509418"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg 95: 744-750, 2008.","DOI":"10.1002\/bjs.6081"},{"key":"38","unstructured":"38. Cai M, Huang W, Lin C, et al. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol 26: 370-380, 2016."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hayashi H, Beppu T, Masuda T, et al. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 22: 1638-1642, 2007.","DOI":"10.1111\/j.1440-1746.2007.05090.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/9\/60_6267-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T03:57:59Z","timestamp":1619841479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/9\/60_6267-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6267-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}